ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2026
Determinants of olfactory cleft targeting in intranasal aerosol delivery: a combined computational and experimental study.
Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveEfficient targeting of the olfactory cleft remains a key barrier to olfactory-targeted intranasal therapy and emerging nose-to-brain (N2B) delivery strategies. However, the upstream aerodynamic mechanisms governing aerosol access to the olfactory cleft during natural inhalation remain insufficiently characterized.
methodsA standardized representative sinonasal model reconstructed from high-resolution CT data of 32 healthy adults was used to evaluate the effects of administration plane, aerosol particle size, and administration angle on olfactory cleft deposition. Airflow and particle transport were simulated using a lattice Boltzmann-discrete particle method (LBM-DPM) framework across 108 parameterized conditions under natural inhalation. A geometry-consistent 3D-printed nasal model combined with radiotracer-based SPECT/CT imaging was used to experimentally validate deposition trends across administration planes.
resultsUnder nebulized delivery during natural inhalation, administration plane and aerosol particle size were the primary determinants of olfactory deposition efficiency, whereas administration angle exerted minimal influence. Shallow insertion facilitated upstream aerosol transport toward the olfactory cleft, with particles of approximately 7 μm achieving the highest and stable deposition efficiency across conditions. A modest interaction between insertion depth and particle size was observed without altering the optimal delivery configuration. In vitro radiotracer experiments demonstrated consistent deposition trends across administration planes compared with numerical simulations, supporting the model predictions.
conclusionUnder physiological inhalation, shallow nozzle positioning combined with intermediate-sized aerosol particles represents an optimal parameter configuration for olfactory-targeted intranasal aerosol delivery. These findings provide quantitative guidance for optimizing intranasal administration parameters and may support the development of nebulized delivery systems for olfactory-targeted therapies.
Indexed as
Identifiers
42249898What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.